| Original language | English |
|---|---|
| Pages (from-to) | 79-81 |
| Number of pages | 3 |
| Journal | European Neurology |
| Volume | 79 |
| Issue number | 1-2 |
| DOIs | |
| State | Published - 1 Mar 2018 |
Bibliographical note
Funding Information:S.-J.C. was involved as a site investigator of multicenter trial sponsored by Ot-suka Korea, Eli Lilly and Company, Korea BMS, and Eisai Korea, and received research support from Hallym University Research Fund 2016 and lecture honoraria from Yuyu Pharmaceutical Company. M.-K.C. was involved as a site investigator for a multicenter trial sponsored by Eli Lilly and company, worked an advisory member for Teva, and received lecture honoraria from Allergan Korea and Yuyu Pharmaceutical Company in the past 24 months. J.-W.P. reports no conflict of interest. S.-G.P. reports no conflict of interest.
Funding Information:
This study received support from Hal- lym University Research Fund 2014 (HURF-2014-51) and research fund from the Korean Headache Society.